Company Performance Metrics
Sinocord, operated by Shandong Qilu Stem Cells Engineering Co., Ltd., manages the Shandong Province Cord Blood Bank. The organization focuses on the collection, processing, and storage of umbilical cord blood hematopoietic stem cells, which are utilized in treatments for various blood and immune system disorders. The facility adheres to national
health regulations and has obtained accreditation from the Foundation for the Accreditation of Cellular Therapy (FACT), indicating compliance with specific standards in cord blood banking. Sinocord's operations include automated liquid nitrogen storage systems with continuous monitoring and infrared alarm capabilities. The organization has stored over 600,000 cord blood units and has released more than 15,000 units for clinical applications, such as leukemia and thalassemia treatments. Sinocord also engages in public health initiatives, including the establishment of a cord blood assistance fund in collaboration with the Shandong Red Cross Society. The organization provides services to families seeking to store cord blood for potential future medical use.